AVEO Pharmaceuticals Inc.

(NASDAQ:AVEO) Trade

By |

Equities News

Company chart and information is provided by TradingView based on 15-minute-delayed data.


Profile

AVEO Pharmaceuticals Inc is a biopharmaceutical company dedicated to advancing a broad portfolio of targeted medicines for oncology and other areas of unmet medical need. The company's aim is to retain North American rights to its oncology portfolio while securing partners in development and commercialization outside of North America. It is seeking to develop and commercialize its lead candidate tivozanib in North America as a treatment for advanced or metastatic renal cell carcinoma (RCC). It has out-licensed tivozanib (FOTIVDA) for oncology in Europe and other territories outside North America.

Contact Information

Website: www.aveooncology.com
Email: aveo@argotpartners.com
Main Phone: +1 857 400-0101
Address: 30 Winter Street
Address 2: 14th Floor
State: MA
City / Town: Boston
Country: US
Postal Code: 02108

Issuer Information

Exchange: NSC
CEO: Michael P. Bailey
Employees: 94
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

View More
(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange N/A